From Personal Loss to Purpose: How Impruvon Is Transforming Medication Management
Back in October 2025, at the TEDCO Expo, Chris Frew, CEO of BioBuzz, sat down with Impruvon CEO Justin Amoyal to talk about the problem his company is tackling, and why it’s so personal.
LEARN MORE